Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEAR2: Pharmacogenomic Evaluation of Antihypertensive Responses
NCT01203852Phase 4Completed
- Sponsor
- University of Florida
- Start
- Aug 2010
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metoprolol, chlorthalidone in hypertension (HTN), sponsored by University of Florida. Started Aug 2010; status: completed.
02
Drugs
metoprololchlorthalidone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01203852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01203852.